QGK-27197-76722 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-09
Dose 1 — Pfizer-BioNTech
2021-01-30
Dose 2 — Pfizer-BioNTech
2021-09-26
Registered in v-safe
2021-09-27
Dose 3 — Pfizer-BioNTech
2021-10-01
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-02
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-03
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Fatigue or tiredness, Nausea

Adult check-in
2021-10-04
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-10-11
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-10-19
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-10-26
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-11-01
Survey response — day 35, dose 3
MedDRA: Headache — Feeling: Good

Free text: Mild, intermittent headache

MedDRA releases: 2024-11 · check-in free text available
2021-11-08
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2021-12-27
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-09-27
Survey response — 12 months, dose 3
MedDRA: Perinatal depression — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Postpartum, depression

MedDRA releases: 2024-11 · check-in free text available
2022-09-27
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-09-28
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-09	Pfizer-BioNTech	No
2	2021-01-30	Pfizer-BioNTech	No
3	2021-09-27	Pfizer-BioNTech	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 10 — day 35, dose 3

2021-11-01

Symptoms: Mild, intermittent headache

Release 12 — 12 months, dose 3

2022-09-27

Symptoms: Postpartum, depression

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Headache	·	·	✓
SD	Perinatal depression	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release